STIs: Antibiotic Resistance and Treatment Challenges
Antibiotic- resistance among sexually transmitted infections (STIs) has continued to escalate over the years. Dive into this article to gain valuable insights into the latest therapeutic plans and evidence-based strategies for optimal patient care!
Course Details
Overview
Antibiotic-resistant infections result in over 2 million cases and 23,000 deaths annually in the United States. While not all sexually transmitted infections (STIs) have documented antibiotic resistance, some are at risk of developing resistance to the only available treatments. This article will help you understand the distinction between antibiotic resistance and persistence, explore various STIs and their therapeutic plans, and consider future treatment options and guidelines. By enhancing your knowledge of antibiotic-resistant STIs, you will gain valuable insights into evidence-based clinical practice and the most effective patient care strategies.
Key Learning Outcomes
- Describe the clinical features, epidemiology, and treatment recommendations for common bacterials STI
- Explain the challenges related to antibotic resistance in bacterial STIs and the importance of appropriate treatment and follow-up
- Identify emerging alternative therapies and prevention strategies for bacterial STIs
Presented by:
Christie Cavallo, EdD, RN, CNE, CHSE
Christie Cavallo is an assistant professor in the division of nurisng at Baptist Health Sciences University in Memphis, Tennessee.
